Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? (Q48173300)

9 February 2018

title

Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? (English)

1 reference

9 February 2018

0 references

0 references

9

1 reference

9 February 2018

Tomasz Gos

4

object named as

Tomasz Gos

1 reference

9 February 2018

author name string

Mandy Busse

1

1 reference

9 February 2018

Stefan Busse

2

1 reference

9 February 2018

Aye Mu Myint

3

1 reference

9 February 2018

Henrik Dobrowolny

5

1 reference

9 February 2018

Ulf J Müller

6

1 reference

9 February 2018

Bernhard Bogerts

7

1 reference

9 February 2018

Hans-Gert Bernstein

8

1 reference

9 February 2018

publication date

20 November 2014

1 reference

9 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

9 February 2018

volume

265

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

321-329

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00406-014-0562-0

exact match

0 references

cites work

Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Expression of the kynurenine pathway enzymes in human microglia and macrophages

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

21 January 2018

12 December 2020

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Increased cerebrospinal fluid glutamine levels in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Tryptophan metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Differential vulnerability of central neurons of the rat to quinolinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

The NMDA receptor as a target for cognitive enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Connecting inflammation with glutamate agonism in suicidality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Glucocorticoid enhances the neurotoxic actions of quinolinic acid in the striatum in a cell-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal volume reduction in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal changes in patients with a first episode of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal/amygdala volumes in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hypercortisolemia and hippocampal changes in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal morphometry in depressed patients and control subjects: relations to anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Temporal lobe measurement in primary affective disorder by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Hippocampal volume and antidepressant response in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Course of illness, hippocampal function, and hippocampal volume in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-014-0562-0

Quantitative MRI of the hippocampus and amygdala in severe depression

21 January 2018

1 reference

12 December 2020

Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula

1 reference

12 December 2020

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

1 reference

12 December 2020

Major depressive disorder is associated with elevated monocyte counts

1 reference

12 December 2020

Sedative/hypnotic dependence: patient stabilization, tolerance testing, and withdrawal.

1 reference

12 December 2020

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?

1 reference

12 December 2020

Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity?

1 reference

12 December 2020

Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics.

1 reference

12 December 2020

The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation

1 reference

12 December 2020

Hippocampal volume in geriatric depression

1 reference

12 December 2020

Increased serum glutamate in depressed patients

1 reference

12 December 2020

10.1007/S00406-014-0562-0

Identifiers

DOI

1 reference

9 February 2018

release_c5iedrmdajahdmorjlt5ew64pu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c5iedrmdajahdmorjlt5ew64pu

24 November 2022

mapped directly with Wikidata item

1 reference

9 February 2018